ReviewFrontiers in immunology2018

Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond.

Kristina Buder-Bakhaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.